These results suggest that the ability of the inhibitor of miR-106b to block the uncontrolled cell cycle progression typical of melanoma cells and to induce their G1-phase arrest is mediated through suppression of the levels of cyclins and CDKs and reactivation of the tumor suppressor protein, p21/WAF1/Cip1. The gene discussed is PCNA; the disease is melanoma.